Skip to main content
Presentation
Mortality rates of patients treated with Drotrecogin alfa for severe Sepsis based on PROWESS eligibility
Pharmacy Practice
  • M. Goodwin
  • R. H. Drew
  • D. B. May
  • A. Scates
  • E. Dodds-Ashley
Document Type
Presentation
Date of Publication
1-1-2007
Event
ACCP Annual Meeting
Location
Denver, CO
Citation Information
M. Goodwin, R. H. Drew, D. B. May, A. Scates, et al.. "Mortality rates of patients treated with Drotrecogin alfa for severe Sepsis based on PROWESS eligibility" (2007)
Available at: http://works.bepress.com/dbyron-may/37/